| human | Q5 |
| P269 | IdRef ID | 095661085 |
| P213 | ISNI | 0000000116290063 |
| P8189 | National Library of Israel J9U ID | 987007332390505171 |
| P691 | NL CR AUT ID | xx0307204 |
| P1207 | NUKAT ID | n2007122033 |
| P496 | ORCID iD | 0000-0002-6088-2979 |
| P214 | VIAF ID | 42127107 |
| P69 | educated at | Wayne State University | Q349055 |
| P108 | employer | University of Pennsylvania | Q49117 |
| P734 | family name | Robertson | Q2159662 |
| Robertson | Q2159662 | ||
| Robertson | Q2159662 | ||
| P101 | field of work | virology | Q7215 |
| microbiology | Q7193 | ||
| molecular genetics | Q210506 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | geneticist | Q3126128 |
| university teacher | Q1622272 | ||
| virologist | Q15634281 | ||
| microbiologist | Q3779582 | ||
| P21 | sex or gender | male | Q6581097 |
| Q40273679 | A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells |
| Q45413909 | A peptide-based inhibitor for prevention of B cell hyperproliferation induced by Epstein-Barr virus |
| Q40106826 | A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia |
| Q28535343 | A unique SUMO-2-interacting motif within LANA is essential for KSHV latency |
| Q42592331 | Activation of mTORC1 signaling pathway in AIDS-related lymphomas |
| Q40377835 | Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum. |
| Q38791533 | An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation |
| Q40051226 | An autonomous replicating element within the KSHV genome |
| Q38664787 | An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation. |
| Q96636754 | Bromodomain-Containing Protein BRD4 Is Hyperphosphorylated in Mitosis |
| Q39675686 | Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores |
| Q36086302 | Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis |
| Q92356645 | Building research capacity through programme development and research implementation in resource-limited settings - the Ipabalele study protocol: observational cohort studies determining the effect of HIV on the natural history of cervical cancer in |
| Q40855155 | COX-2 induces lytic reactivation of EBV through PGE2 by modulating the EP receptor signaling pathway |
| Q35943718 | Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression. |
| Q30919397 | Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus. |
| Q36241967 | Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs |
| Q35237492 | Chromatinization of the KSHV Genome During the KSHV Life Cycle |
| Q34542133 | Clinical implications of human papillomavirus infection |
| Q33873223 | Collision of Three Pandemics: The Coexistence of Cervical Cancer, HIV Infection, and Prior Tuberculosis in the Sub-Saharan Country of Botswana |
| Q28533244 | Comprehensive analysis of LANA interacting proteins essential for viral genome tethering and persistence |
| Q40338623 | Conserved cell cycle regulatory properties within the amino terminal domain of the Epstein-Barr virus nuclear antigen 3C. |
| Q36086197 | Constitutive Activation of Interleukin-13/STAT6 Contributes to Kaposi's Sarcoma-Associated Herpesvirus-Related Primary Effusion Lymphoma Cell Proliferation and Survival |
| Q34005284 | Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation |
| Q64065061 | Correction: Shugoshin 1 is dislocated by KSHV-encoded LANA inducing aneuploidy |
| Q47606345 | Current Progress in EBV-Associated B-Cell Lymphomas |
| Q38337443 | Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C. |
| Q43099955 | Detection of Epstein-Barr virus in T-cell prolymphocytic leukemia cells in vitro |
| Q38286347 | Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation |
| Q55345322 | Distinct Microbial Signatures Associated With Different Breast Cancer Types. |
| Q36164563 | Distinct microbiological signatures associated with triple negative breast cancer |
| Q50289885 | Dysregulated cytokine and growth factor expression in OSSN HIV-1 patients from Botswana with multiple infections |
| Q34205875 | E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells. |
| Q34741776 | EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5 |
| Q35224422 | EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation |
| Q39900063 | EBNA3C can modulate the activities of the transcription factor Necdin in association with metastasis suppressor protein Nm23-H1. |
| Q61450799 | EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation |
| Q38908573 | EBNA3C regulates p53 through induction of Aurora kinase B. |
| Q42273501 | EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases |
| Q36109083 | EBV Nuclear Antigen 3C Mediates Regulation of E2F6 to Inhibit E2F1 Transcription and Promote Cell Proliferation. |
| Q64971530 | EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis. |
| Q33261811 | EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors |
| Q28476230 | Early events associated with infection of Epstein-Barr virus infection of primary B-cells |
| Q59350125 | Editorial overview: Viruses and cancer |
| Q28068361 | Epigenetic Impact on EBV Associated B-Cell Lymphomagenesis |
| Q36258923 | Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues |
| Q52565524 | Epigenetic Regulation of Tumor Suppressors by Helicobacter pylori Enhances EBV-Induced Proliferation of Gastric Epithelial Cells. |
| Q36079181 | Epigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection. |
| Q39943472 | Epstein-Barr Virus (EBV): infection, propagation, quantitation, and storage |
| Q59357136 | Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2 |
| Q98733012 | Epstein-Barr Virus facilitates expression of KLF14 by regulating the cooperative binding of E2F-Rb-HDAC complex in latent infection |
| Q39629572 | Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin |
| Q28074586 | Epstein-Barr Virus: Diseases Linked to Infection and Transformation |
| Q40624679 | Epstein-Barr virus detected in a head and neck squamous cell carcinoma cell line derived from an immunocompromised patient. |
| Q38854742 | Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression |
| Q38603533 | Epstein-Barr virus latency: current and future perspectives |
| Q24535609 | Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase |
| Q36692186 | Epstein-Barr virus latent antigens EBNA3C and EBNA1 modulate epithelial to mesenchymal transition of cancer cells associated with tumor metastasis |
| Q36099024 | Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model |
| Q33718191 | Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration |
| Q24537547 | Epstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3/HAT domains and cooperate in regulation of transcription and histone acetylation. |
| Q39879529 | Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2. |
| Q33828576 | Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1. |
| Q24311421 | Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein |
| Q24540313 | Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2. |
| Q34782258 | Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines |
| Q40594951 | Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity |
| Q34102722 | Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis |
| Q34872837 | Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities |
| Q34302223 | Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1 |
| Q37849461 | Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes |
| Q104749968 | Erratum for Jha et al., "Gammaherpesvirus Infection of Human Neuronal Cells" |
| Q104479288 | Erratum for Pandey et al., "Epigenetic Regulation of Tumor Suppressors by Helicobacter pylori Enhances EBV-Induced Proliferation of Gastric Epithelial Cells" |
| Q36119183 | Evidence of an oncogenic gammaherpesvirus in domestic dogs |
| Q40288802 | Expression of alpha V integrin is modulated by Epstein-Barr virus nuclear antigen 3C and the metastasis suppressor Nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors |
| Q34901718 | Functional modulation of the metastatic suppressor Nm23-H1 by oncogenic viruses |
| Q36870503 | G-quadruplex-interacting compounds alter latent DNA replication and episomal persistence of KSHV. |
| Q36346036 | Gammaherpesvirus Infection of Human Neuronal Cells |
| Q112709046 | Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya |
| Q36760020 | H2AX phosphorylation is important for LANA-mediated Kaposi's sarcoma-associated herpesvirus episome persistence |
| Q100380630 | Herpesvirus Epigenetic Reprogramming and Oncogenesis |
| Q26744568 | Human Oncogenic Herpesvirus and Post-translational Modifications - Phosphorylation and SUMOylation |
| Q33543092 | Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification |
| Q36445869 | IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes. |
| Q35034278 | IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation |
| Q99708270 | Identification of a 3-β-homoalanine conjugate of brusatol with reduced toxicity in mice |
| Q37013300 | Identification of fungal pathogens in a patient with acute myelogenic leukemia using a pathogen detection array technology |
| Q38086861 | Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis |
| Q81110339 | Increased viral load correlates with improved survival in HPV-16-associated tonsil carcinoma patients |
| Q33843211 | Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency |
| Q33743831 | Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ. |
| Q39794624 | Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor. |
| Q40267803 | Intracellular activated Notch1 is critical for proliferation of Kaposi's sarcoma-associated herpesvirus-associated B-lymphoma cell lines in vitro |
| Q40279784 | Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency |
| Q34125957 | Isolation and characterization of mouse and human esophageal epithelial cells in 3D organotypic culture |
| Q81928431 | Isolation of human peripheral blood mononuclear cells (PBMCs) |
| Q34774797 | KSHV LANA--the master regulator of KSHV latency |
| Q40286016 | KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity |
| Q36087231 | KSHV-Mediated Regulation of Par3 and SNAIL Contributes to B-Cell Proliferation |
| Q93074235 | KSHV-encoded LANA protects the cellular replication machinery from hypoxia induced degradation |
| Q34186981 | Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation |
| Q36019173 | Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein |
| Q39940851 | Kaposi's sarcoma-associated herpesvirus RTA activates the processivity factor ORF59 through interaction with RBP-Jkappa and a cis-acting RTA responsive element. |
| Q30369871 | Kaposi's sarcoma-associated herpesvirus genome programming during the early stages of primary infection of peripheral blood mononuclear cells. |
| Q39665994 | Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency |
| Q42049779 | Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions |
| Q33737793 | Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway |
| Q40607781 | Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1 |
| Q30482603 | Kaposi's sarcoma-associated herpesvirus-encoded LANA can interact with the nuclear mitotic apparatus protein to regulate genome maintenance and segregation |
| Q38859450 | Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin |
| Q40335991 | Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function |
| Q34194120 | Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency |
| Q24543014 | Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats |
| Q35192868 | Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen reduces interleukin-8 expression in endothelial cells and impairs neutrophil chemotaxis by degrading nuclear p65. |
| Q64232572 | LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency |
| Q52695024 | Lactic Acid Downregulates Viral MicroRNA To Promote Epstein-Barr Virus-Immortalized B Lymphoblastic Cell Adhesion and Growth. |
| Q40317413 | Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats |
| Q39852047 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation |
| Q24670086 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus |
| Q39992257 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. |
| Q39932357 | MTA1 expression is linked to ovarian cancer |
| Q38760916 | Major Histocompatibility Complex Class II HLA-DRα Is Downregulated by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Lytic Transactivator RTA and MARCH8. |
| Q93010927 | Mechanisms of B-Cell Oncogenesis Induced by Epstein-Barr Virus |
| Q53781024 | Metabolic reprogramming of Kaposi's sarcoma associated herpes virus infected B-cells in hypoxia. |
| Q34229868 | Metagenomic assay for identification of microbial pathogens in tumor tissues |
| Q33826237 | Microbial Signatures Associated with Oropharyngeal and Oral Squamous Cell Carcinomas |
| Q91829257 | Microbiome signatures in prostate cancer |
| Q90319833 | Molecular Biology of EBV in Relationship to HIV/AIDS-Associated Oncogenesis |
| Q35124404 | Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis |
| Q35138059 | Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus |
| Q30363183 | Molecular biology of EBV in relationship to AIDS-associated oncogenesis. |
| Q34508530 | Molecular biology of Kaposi's sarcoma-associated herpesvirus |
| Q35928895 | Molecular genetics of herpesviruses: a recombinant technology approach. |
| Q30387346 | Multiple oncogenic viruses identified in Ocular surface squamous neoplasia in HIV-1 patients |
| Q39706788 | Nm23-H1 can induce cell cycle arrest and apoptosis in B cells |
| Q24311795 | Nm23-H1 modulates the activity of the guanine exchange factor Dbl-1 |
| Q36252859 | Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency |
| Q37468665 | Nucleoside diphosphate kinase/Nm23 and Epstein-Barr virus |
| Q40173321 | ORF73 of Herpesvirus Saimiri Strain C488 Tethers the Viral Genome to Metaphase Chromosomes and Binds to cis -Acting DNA Sequences in the Terminal Repeats |
| Q37511491 | ORF73 of herpesvirus saimiri, a viral homolog of Kaposi's sarcoma-associated herpesvirus, modulates the two cellular tumor suppressor proteins p53 and pRb. |
| Q45326277 | Oncogenic Epstein-Barr virus recruits Nm23-H1 to regulate chromatin modifiers |
| Q37722565 | Oncogenic viral prevalence in invasive vulvar cancer specimens from human immunodeficiency virus-positive and -negative women in Botswana |
| Q34182459 | Oncogenic viruses associated with vulva cancer in HIV-1 patients in Botswana |
| Q89857570 | Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway |
| Q33282107 | Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA. |
| Q41866484 | Proteomic analysis of the Kaposi's sarcoma-associated herpesvirus terminal repeat element binding proteins |
| Q41306617 | Proteomic profiling identifies the SIM-associated complex of KSHV-encoded LANA. |
| Q79383523 | Proteomic signatures in laryngeal squamous cell carcinoma |
| Q95934035 | Quassinoid analogs with enhanced efficacy for treatment of hematologic malignancies target the PI3Kγ isoform |
| Q39602242 | Regulation of Nm23-H1 and cell invasiveness by Kaposi's sarcoma-associated herpesvirus |
| Q40398026 | Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1. |
| Q38246971 | Regulation of the metastasis suppressor Nm23-H1 by tumor viruses |
| Q91864003 | Role of SUMOylation in Human Oncogenic Herpesvirus Infection |
| Q24556627 | SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen |
| Q60304783 | STAT6 degradation and ubiquitylated TRIML2 are essential for activation of human oncogenic herpesvirus |
| Q90356763 | STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency |
| Q58744059 | Shugoshin 1 is dislocated by KSHV-encoded LANA inducing aneuploidy |
| Q34071388 | Single molecule analysis of replicated DNA reveals the usage of multiple KSHV genome regions for latent replication |
| Q35007967 | Small molecule growth inhibitors of human oncogenic gammaherpesvirus infected B-cells |
| Q52422473 | Survival of the fittest: a role for phage-encoded eukaryotic-like kinases. |
| Q99359096 | Targeted Therapies for Epstein-Barr Virus-Associated Lymphomas |
| Q35857290 | The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block |
| Q104061704 | The Crosstalk of Epigenetics and Metabolism in Herpesvirus Infection |
| Q34711793 | The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8. |
| Q34542141 | The Epstein Barr nuclear antigen EBNA3C regulates transcription, cell transformation and cell migration |
| Q34130213 | The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation |
| Q26767186 | The Role of Gammaherpesviruses in Cancer Pathogenesis |
| Q34362138 | The metastatic suppressor Nm23-H1 interacts with EBNA3C at sequences located between the glutamine- and proline-rich domains and can cooperate in activation of transcription |
| Q40199723 | The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner |
| Q33829460 | The ovarian cancer oncobiome |
| Q35077558 | The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection |
| Q39946955 | The suppressor of metastasis Nm23-H1 interacts with the Cdc42 Rho family member and the pleckstrin homology domain of oncoprotein Dbl-1 to suppress cell migration |
| Q89793209 | The virome of HPV-positive tonsil squamous cell carcinoma and neck metastasis |
| Q54978478 | Transcriptional and epigenetic modulation of autophagy promotes EBV oncoprotein EBNA3C induced B-cell survival. |
| Q37810431 | Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention |
| Q34115236 | Ubiquitin/SUMO Modification Regulates VHL Protein Stability and Nucleocytoplasmic Localization |
| Q34013770 | Upregulation of cellular Bcl-2 by the KSHV encoded RTA promotes virion production |
| Q102220195 | Vascular endothelial growth factor encoded by Parapoxviruses can regulate metabolism and survival of triple negative breast cancer cells |
| Q35940416 | Viral-associated trichodysplasia: characterization of a novel polyomavirus infection with therapeutic insights |
| Q28476790 | miR-K12-7-5p encoded by Kaposi's sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA |
Search more.